+28.2%
MRNA vs P
+144.8%
-116.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | P | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -4.0% | +0.7% | -3.0% |
| 7D | -10.1% | +5.0% | -15.1% | -10.5% |
| 30D | +126.7% | -0.9% | +127.7% | +123.2% |
| 3M | +184.1% | +38.7% | +145.5% | +162.6% |
| 6M | +143.3% | +54.4% | +88.9% | +118.0% |
| YTD | +359.9% | +44.8% | +315.0% | +314.7% |
| 1Y | +454.2% | +22.5% | +431.7% | +402.0% |
| All | +28.2% | +144.8% | -116.6% | -1.7% |
Cumulative growth
Daily Returns
Daily percentage return beside P.
Daily Out/Under-Performance
Portfolio return minus P return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × P return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded P wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling